Wednesday, December 11, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

NEWS

China approves second homegrown antiviral pill to fight Covid-19

china-pildoras-covid-300x225
Beijing, Sep 26 (Prensa Latina) China's health regulators have just approved to take the second homegrown antiviral pill to fight off Covid-19 to clinical trials, amid constant fresh outbreaks of the Omicron variant, the media reported on Monday.

According to the Global Times, the new pill -called GST-HG171- was obtained by Cosunter Pharmaceutical Co Ltd (COSUNTER) in the eastern province of Fujian. This drug can be used preventively.

Tests will be conducted on adult patients with mild-to-moderate Covid-19 symptoms, after proving a strong antiviral effect in animal studies.

Aside from GST-HG171, there are more than 10 oral drugs underway and under research in China to fight off Covid-19.

In July, health regulators authorized the country to apply the homegrown antiviral Azvudine pill following clinical studies found that 40.4% of volunteers showed a positive health progress in just seven days.

Previously, China endorsed the U.S. company Paxlovid, launched on the market a treatment that helps boost neutralizing antibody outputs and started off by applying the Evusheld vaccine manufactured by the British-Swedish company AstraZeneca.

Companies Sinopharm and Sinovac are together testing specific vaccines against the Omicron new variant, and CanSinoBIO has already been given the go-ahead for clinical trials with an mRNA-type vaccine.

pll/jf/ymr

LATEST NEWS
RELATED